HCCS
Basic information
Region (hg38): X:11111301-11123086
Previous symbols: [ "MLS" ]
Links
Phenotypes
GenCC
Source:
- linear skin defects with multiple congenital anomalies 1 (Definitive), mode of inheritance: XLD
- linear skin defects with multiple congenital anomalies (Supportive), mode of inheritance: XL
- linear skin defects with multiple congenital anomalies 1 (Strong), mode of inheritance: XL
- linear skin defects with multiple congenital anomalies 1 (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Linear skin defects with multiple congenital anomalies 1 (MIDAS syndrome) | XL | Audiologic/Otolaryngologic; Cardiovascular | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; As individuals have been described with a variety of cardiovascular anomalies, surveillance (eg, with echocardiogram/electrocardiogram) may allow detection and early management of related manifestations | Audiologic/Otolaryngologic; Cardiovascular; Dermatologic; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic | 16059943; 17033964; 17893649; 20301767; 21200317 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HCCS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 15 | ||||
missense | 15 | 24 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 10 | |||||
Total | 1 | 3 | 15 | 20 | 12 |
Variants in HCCS
This is a list of pathogenic ClinVar variants found in the HCCS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-11112062-T-C | Linear skin defects with multiple congenital anomalies 1 | Likely pathogenic (Mar 25, 2024) | ||
X-11112064-G-A | Benign (Dec 11, 2023) | |||
X-11112065-G-A | not specified • Intellectual disability • Inborn genetic diseases • HCCS-related disorder | Conflicting classifications of pathogenicity (Dec 02, 2023) | ||
X-11112078-T-C | Likely benign (Dec 21, 2023) | |||
X-11112081-T-C | Likely benign (Nov 22, 2022) | |||
X-11112106-A-G | Inborn genetic diseases | Likely benign (Oct 03, 2022) | ||
X-11112125-C-T | Uncertain significance (Apr 03, 2023) | |||
X-11112154-A-T | not specified | Likely benign (Nov 03, 2015) | ||
X-11112155-T-C | Uncertain significance (Mar 06, 2015) | |||
X-11114527-C-T | Likely benign (Feb 05, 2019) | |||
X-11114824-G-C | Likely benign (Nov 01, 2022) | |||
X-11114865-C-T | Inborn genetic diseases | Uncertain significance (Oct 17, 2024) | ||
X-11114895-C-T | Uncertain significance (Jun 27, 2017) | |||
X-11114902-C-A | Inborn genetic diseases | Uncertain significance (Jul 08, 2021) | ||
X-11114909-C-A | Uncertain significance (Jan 16, 2024) | |||
X-11114909-C-T | Benign (Oct 27, 2023) | |||
X-11114911-C-T | Benign (Sep 29, 2023) | |||
X-11114912-G-A | Inborn genetic diseases | Uncertain significance (Jan 23, 2023) | ||
X-11114916-A-G | Uncertain significance (Jun 25, 2023) | |||
X-11114923-C-T | HCCS-related disorder | Benign (Dec 21, 2023) | ||
X-11114929-G-A | HCCS-related disorder | Likely benign (Apr 20, 2020) | ||
X-11114933-C-A | Linear skin defects with multiple congenital anomalies 1 | Uncertain significance (May 03, 2020) | ||
X-11114949-C-T | not specified • Inborn genetic diseases | Benign/Likely benign (Jan 29, 2024) | ||
X-11114950-G-C | not specified • History of neurodevelopmental disorder | Benign/Likely benign (Dec 22, 2023) | ||
X-11114970-T-C | Uncertain significance (Sep 01, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HCCS | protein_coding | protein_coding | ENST00000321143 | 6 | 11778 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.886 | 0.114 | 125642 | 0 | 1 | 125643 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.20 | 75 | 110 | 0.680 | 0.00000875 | 1751 |
Missense in Polyphen | 14 | 44.892 | 0.31186 | 727 | ||
Synonymous | 0.533 | 37 | 41.4 | 0.895 | 0.00000357 | 488 |
Loss of Function | 2.86 | 1 | 11.5 | 0.0873 | 8.94e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000626 | 0.0000464 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Links covalently the heme group to the apoprotein of cytochrome c. {ECO:0000250}.;
- Disease
- DISEASE: Linear skin defects with multiple congenital anomalies 1 (LSDMCA1) [MIM:309801]: A disorder characterized by dermal, ocular, neurological and cardiac abnormalities. LSDMCA1 main features are unilateral or bilateral microphthalmia, linear skin defects in affected females, and in utero lethality for males. Skin defects are limited to the face and neck, consisting of areas of aplastic skin that heal with age to form hyperpigmented areas. Additional features in female patients include agenesis of the corpus callosum, sclerocornea, chorioretinal abnormalities, infantile seizures, congenital heart defect, mental retardation, and diaphragmatic hernia. Microphthalmia is a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. {ECO:0000269|PubMed:17033964}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Porphyrin and chlorophyll metabolism - Homo sapiens (human);Porphyrin metabolism
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.11
Haploinsufficiency Scores
- pHI
- 0.114
- hipred
- Y
- hipred_score
- 0.654
- ghis
- 0.462
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.944
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hccs
- Phenotype
- normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype;
Gene ontology
- Biological process
- animal organ morphogenesis;cytochrome c-heme linkage;oxidation-reduction process
- Cellular component
- mitochondrion;mitochondrial inner membrane
- Molecular function
- holocytochrome-c synthase activity;metal ion binding